{
  "id": 1492932,
  "title": "AstraZeneca Reports Mixed Lung Cancer Trial Results",
  "url": "https://urgent.news/2026/08/17/astrazeneca-reports-mixed-lung-cancer-trial-results",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-08-17T13:57:21.000Z",
  "source": {
    "name": "Bloomberg",
    "slug": "bloomberg",
    "url": "https://www.bloomberg.com/news/videos/2026-08-17/astrazeneca-reports-mixed-lung-cancer-trial-results-video"
  },
  "original_language": "en",
  "account": null,
  "summary": "AstraZeneca is stopping a clinical trial of the experimental drug volrustomig as it didn’t look set to help fight lung cancer better than existing therapies. The company had two separate late-stage trial successes that strengthen key cancer franchises, including one where patients with non-small cell lung cancer received Tagrisso in combination with Orpathys. Bloomberg Intelligence's Sam Fazeli…",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}